JAMA News
Most Popular JAMA Story
Scientists recommend 'black box' for Avastin
A report released in the new issue of the Journal of the American Medical Association said that Genentech's blockbuster cancer drug, Avastin, could raise the risk of blood clots by about 12 percent,... Read more...
Latest Headlines
- November 19, 2008
- October 8, 2008
- May 21, 2008
- April 23, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
